New adenovirus-based vaccine vectors targeting Pfs25 elicit antibodies that inhibit Plasmodium falciparum transmission

Antibody responses to prime–boost vaccination with an HIV-1 gp145 envelope protein and chimpanzee adenovirus vectors expressing HIV-1 gp140

(2016) Kristel L. Emmer et al.   AIDS

Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data

(2016)   BMC Medicine

Germinal Center B Cell and T Follicular Helper Cell Responses to Viral Vector and Protein-in-Adjuvant Vaccines

(2016) Chuan Wang et al.   JOURNAL OF IMMUNOLOGY

Factors Associated with Non-Participation and Non-Adherence in Directly Observed Mass Drug Administration for Malaria in The Gambia

(2016) Susan Dierickx et al.   PLoS One

Antimalarial mass drug administration: ethical considerations

(2016) Phaik Yeong Cheah et al.   International Health

Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology

(2016) Yuanyuan Li et al.   Scientific Reports

Toward the development of effective transmission-blocking vaccines for malaria

(2015) Daria Nikolaeva et al.   Expert Review of Vaccines

Numerical Distributions of Parasite Densities During Asymptomatic Malaria

(2015) Mallika Imwong et al.   JOURNAL OF INFECTIOUS DISEASES

Ultra-Sensitive Detection of Plasmodium falciparum by Amplification of Multi-Copy Subtelomeric Targets

(2015) Natalie Hofmann et al.   PLOS MEDICINE

SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information

(2014) Marco Biasini et al.   NUCLEIC ACIDS RESEARCH

The role of asymptomatic P. falciparum parasitaemia in the evolution of antimalarial drug resistance in areas of seasonal transmission

(2013) Hamza A. Babiker et al.   DRUG RESISTANCE UPDATES

Qualification of Standard Membrane-Feeding Assay with Plasmodium falciparum Malaria and Potential Improvements for Future Assays

(2013) Kazutoyo Miura et al.   PLoS One

Malaria vaccines: Focus on adenovirus based vectors

(2012) Nathaniel J. Schuldt et al.   VACCINE

Malaria proteases mediate inside-out egress of gametocytes from red blood cells following parasite transmission to the mosquito

(2011) Ludmilla Sologub et al.   CELLULAR MICROBIOLOGY

The Requirement for Potent Adjuvants To Enhance the Immunogenicity and Protective Efficacy of Protein Vaccines Can Be Overcome by Prior Immunization with a Recombinant Adenovirus

(2011) S. C. de Cassan et al.   JOURNAL OF IMMUNOLOGY

A Viral Vectored Prime-Boost Immunization Regime Targeting the Malaria Pfs25 Antigen Induces Transmission-Blocking Activity

(2011) Anna L. Goodman et al.   PLoS One

Adenovirus-vectored Plasmodium vivax ookinete surface protein, Pvs25, as a potential transmission-blocking vaccine

(2011) Takeshi Miyata et al.   VACCINE

Replacing adenoviral vector HVR1 with a malaria B cell epitope improves immunogenicity and circumvents preexisting immunity to adenovirus in mice

(2010) Takayuki Shiratsuchi et al.   JOURNAL OF CLINICAL INVESTIGATION

A Capsid-Encoded PPxY-Motif Facilitates Adenovirus Entry

(2010) Harald Wodrich et al.   PLoS Pathogens

Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51

(2008) Yimin Wu et al.   PLoS One

Adenovirus vector induced innate immune responses: Impact upon efficacy and toxicity in gene therapy and vaccine applications

(2007) Zachary C. Hartman et al.   VIRUS RESEARCH